SCHEMBL17203201

SCHEMBL17203201

Nc1ncc(Br)cc1-c1cnn(CC(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 4/20 0.46
▸ PIK3CB P42338 4/20 0.46
▸ PIK3CG P48736 4/20 0.46
▸ MTOR P42345 3/20 0.46
▸ LRRK2 Q5S007 3/20 0.44
▸ IRAK4 Q9NWZ3 2/20 0.37
▸ FFAR1 O14842 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ ALOX5AP P20292 2/20 0.36
▸ FEN1 P39748 1/20 0.35
▸ PIM1 P11309 2/20 0.35
▸ PIM3 Q86V86 2/20 0.35
▸ PIM2 Q9P1W9 2/20 0.35
▸ KCNJ5 P48544 1/20 0.35
▸ SCN9A Q15858 2/20 0.35
▸ TYRO3 Q06418 1/20 0.35
▸ PLA2G1B P04054 1/20 0.34
▸ ATG4B Q9Y4P1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28734614 0.77 LRRK2 (0.41) PIK3CDPIK3CBPIK3CGMTORLRRK2
SCHEMBL22558679 0.76 PIK3CD (0.37) PIK3CDPIK3CBPIK3CGMTORLRRK2
SCHEMBL29480681 0.74 LRRK2 (0.44) PIK3CDPIK3CBPIK3CGMTORLRRK2
SCHEMBL17203376 0.74 LRRK2 (0.61) PIK3CDPIK3CBPIK3CGMTORLRRK2
SCHEMBL29582496 0.74 LRRK2 (0.61) PIK3CDPIK3CBPIK3CGMTORLRRK2
SCHEMBL25315734 0.72 KCNH2 (0.50) LRRK2ALOX5APPIM1PIM3PIM2
SCHEMBL8377006 0.70 KCNH2 (0.54) LRRK2KMT2APIM1PIM3PIM2
SCHEMBL671951 0.70 ALDH1A1 (0.43) LRRK2HTTKMT2A
SCHEMBL20359818 0.70 KCNH2 (0.42) LRRK2IRAK4FFAR1
SCHEMBL18985800 0.69 MEN1 (0.42) PIK3CDPIK3CBPIK3CGLRRK2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3134396-B1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2019-09-18 — — EP disclosed
EP-3134396-B1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2019-09-18 — — EP disclosed
US-10112926-B2 Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors NOVARTIS AG (CH) 2018-10-30 — — US disclosed
EP-3134396-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS Novartis AG (CH) 2017-03-01 — — EP disclosed
US-20170037032-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2017-02-09 — — US disclosed
US-20170037032-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2017-02-09 — — US disclosed
US-20170037032-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2017-02-09 — — US disclosed
WO-2015162456-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2015-10-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170037032-A1 AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS PI4KA, PIP4K2B, PHKG1 PIK3CD 15/4885PIK3CB 13/4885PIK3CG 16/4885
US-10112926-B2 Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors PI4KA, PIP4K2B, PHKG1 PIK3CD 15/4885PIK3CB 13/4885PIK3CG 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback